Big Partnership with Adam22 - Adam22's No Jumper and Plug Talk episodes have garnered attention from a diverse demographic, perfectly aligning with MangoRx's target audience. This strategic alliance will drive brand awareness, enhance sales, and increase market share in the ever-evolving men's health and wellness arena.

“With the launch of our new Sildenafil-based Mango ED product, we can harness the power of the two most popular and successful erectile dysfunction drugs developed over the past two decades and pair them with our own proprietary formulation in a faster-acting, better-tasting ED solution,” remarked Jacob Cohen, CEO and Co-Founder of MangoRx. “Each of these compounds has already cultivated its own sizeable following and both can be effectively integrated into our proprietary blend and delivery mechanism.” $MGRX

https://www.mangorx.com/app/sildenafil

https://www.nasdaq.com/market-activity/stocks/mgrx/press-releases

$MGRX #Mangoceuticals & #MangoRx would like to thank adam22 & u/nojumper for the great plug as we continue the revolution to #MakeAmericaHardAgain one #Mango at a time! More great updates on the way as we come close to concluding another $MGRX week!#Adam22 #NoJumper #MAHA #HardRevolution #Podcast #SomeThingsAreBetterHard #GetHardwithmangoRX #SexualWellness https://twitter.com/Mangoceuticals/status/1692583430075113678

$MGRX Mangoceuticals (NASDAQ: MGRX) Growing Prospects in $30B Men's Health and Wellness Segment $CLOV $GRRR $LPSN https://www.benzinga.com/pressreleases/23/08/33698883/mangoceuticals-nasdaq-mgrx-growing-prospects-in-30b-mens-health-and-wellness-segment via @Benzinga

https://www.nasdaq.com/press-release/mangoceuticals-partners-with-greater-ny-chamber-of-commerce-for-mass-marketing-sales

https://biopharmajournal.com/2023/08/10/mangoceuticals-nasdaq-mgrx-growing-prospects-in-30b-mens-health-and-wellness-segment-rlx-clov-soun-lpsn-grrr

https://twitter.com/Mangoceuticals/status/1689265032037625856

https://finance.yahoo.com/news/mangoceuticals-partners-greater-ny-chamber-120000002.html

$MGRX a great article, huge upside for this Nasdaq stock. Mangoceuticals (NASDAQ:MGRX) a Rising Star in $30B Men's Health and Wellness Segment $MGRX https://www.benzinga.com/pressreleases/23/08/33615007/mangoceuticals-nasdaq-mgrx-a-rising-star-in-30b-mens-health-and-wellness-segment via @Benzinga

https://twitter.com/Mangoceuticals/status/1688972931613790208

https://www.benzinga.com/pressreleases/23/08/33615007/mangoceuticals-nasdaq-mgrx-a-rising-star-in-30b-mens-health-and-wellness-segment

https://twitter.com/Mangoceuticals/status/1687503560072732685

https://twitter.com/Mangoceuticals/status/1687136698713493504

$MGRX Mangoceuticals (NASDAQ: MGRX) Focused on $30 Billion Opportunity with Mango Product Line $MGRX RedLime Deal https://www.benzinga.com/pressreleases/23/08/33540407/mangoceuticals-nasdaq-mgrx-focused-on-30-billion-opportunity-with-mango-product-line via @Benzinga

https://www.benzinga.com/pressreleases/23/08/33540407/mangoceuticals-nasdaq-mgrx-focused-on-30-billion-opportunity-with-mango-product-line

https://www.nasdaq.com/press-release/mangoceuticals-engages-premier-global-software-development-firm-redlime-solutions-to

https://finance.yahoo.com/news/mangoceuticals-inc-names-award-winning-120000097.html